BioNTech SE (BNTX) Current Deferred Revenue (2018 - 2026)
BioNTech SE (BNTX) posted Current Deferred Revenue of $101.82 million for Q2 2026, down 88.6% from $891.64 million a year earlier and down 0.8% from the prior quarter.
BioNTech SE (BNTX) Current Deferred Revenue (2018 - 2026) Analysis & Trends
At the end of FY2025, BioNTech SE's Current Deferred Revenue came in at $102.44 million, down 47.6% from FY2024.
- Annual Current Deferred Revenue shows a five-year compound annual growth rate of 4.5% (FY2020 to FY2025).
- In prior years, BioNTech SE's Current Deferred Revenue was $195.55 million in FY2024 (-54.4%), $428.76 million in FY2023 (+768.3%), $49.38 million in FY2022 (+379.6%) and $10.3 million in FY2021 (-87.5%).
- The Q2 2026 figure stands as the lowest quarterly Current Deferred Revenue since Q1 2023.
- On a year-over-year basis, Current Deferred Revenue has declined in each of the last four quarters, with an average decline of 19.1% over the last eight quarters.
- The strongest year-over-year quarter for Current Deferred Revenue in the past five years was Q4 2023, with growth of 768.3%; the weakest was Q2 2026, with a decline of 88.6%.
- According to Business Quant data, Current Deferred Revenue for the three prior quarters was $102.67 million (Q1 2026), $102.44 million (Q4 2025) and $256.02 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn |
| 10 | BioNTech SE | 24.93 Bn | -34.44 Bn | 10.00 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 101.82 Mn |
| Mar 31, 2026 | 102.67 Mn |
| Dec 31, 2025 | 102.44 Mn |
| Sep 30, 2025 | 256.02 Mn |
| Jun 30, 2025 | 891.64 Mn |
| Mar 31, 2025 | 192.39 Mn |
| Dec 31, 2024 | 195.55 Mn |
| Sep 30, 2024 | 413.92 Mn |
| Jun 30, 2024 | 380.79 Mn |
| Mar 31, 2024 | 411.95 Mn |
| Dec 31, 2023 | 428.76 Mn |
| Sep 30, 2023 | 291.74 Mn |
| Jun 30, 2023 | 328.96 Mn |
| Mar 31, 2023 | 48.94 Mn |
| Dec 31, 2022 | 49.38 Mn |
| Sep 30, 2022 | 54.25 Mn |
| Jun 30, 2022 | 59.65 Mn |
| Mar 31, 2022 | 74.52 Mn |
| Dec 31, 2021 | 10.30 Mn |
| Sep 30, 2021 | 12.38 Mn |
BioNTech SE Current Deferred Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=BNTX&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-deferred-revenue", "ticker": "BNTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=BNTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();